In accordance with Article 185 of the Withdrawal Agreement and Article 5(4) of the Protocol on Ireland/Northern Ireland, Union legislation on medicinal products continued to apply in Northern Ireland after the end of the transition period.
Recital 3, Regulation (EU) 2022/315
In forcesince 17 Dec 2021